-
July 1, 2022 Psychedelic Business Spotlight – July 1This week in psychedelic stock news: MindMed downplays delisiting fears; Red Light Holland teams with...
-
July 1, 2022 MindMed Reassures Investors over Nasdaq Delisting FearsIn a Reddit AMA, MindMed CEO Robert Barrow says Nasdaq delisting is not “a risk...
-
June 24, 2022 This Week in Psychedelic Stocks: Compass Pathways Wins Patent Battle, MindMed Patents Candy Flipping, and More!This week in psychedelic stock news, there are big patent developments for Compass, MindMed and...
-
June 10, 2022 Psychedelic Business Spotlight – June 10This week in psychedelic business news: Cybin acquires a Phase 1 DMT trial from Entheon;...
-
June 3, 2022 Does MDMA Reduce Fear? New Study Has Implications for PTSD TreatmentUsing a measurement tool called the SCR, researchers found that combining MDMA with fear extinction...
-
May 17, 2022 Comparing MindMed, Atai Life Sciences, Compass Pathways: A Psychedelic Stock AnalysisOur resident psychedelic investor explains a handful of important metrics to study when analyzing and...
-
May 13, 2022 Psychedelic Business Spotlight – May 13This week in psychedelic business news: Beckley Retreats set launch; another shark swims into the...
-
May 11, 2022 MindMed’s Phase 2 LSD Trial Treating Anxiety Was a SuccessResearchers at PSYCH Symposium reveal promising results from double-blind, placebo-controlled study with 46 patients.
-
May 10, 2022 Why Wednesday Will Be Biggest Day of 2022 for Psychedelic InvestorsPsychedelic investors are about to see pivotal data presented on flagship programs by the titans...
-
April 21, 2022 Kevin O’Leary Predicts These 3 Psychedelic Companies Will Merge, But Should They?Our resident Psychedelic Investor James Hallifax wonders if the "Shark Tank" star's prediction makes financial...
